AU2420195A - Pharmaceutical composition for treating glaucoma containing terazosin - Google Patents

Pharmaceutical composition for treating glaucoma containing terazosin

Info

Publication number
AU2420195A
AU2420195A AU24201/95A AU2420195A AU2420195A AU 2420195 A AU2420195 A AU 2420195A AU 24201/95 A AU24201/95 A AU 24201/95A AU 2420195 A AU2420195 A AU 2420195A AU 2420195 A AU2420195 A AU 2420195A
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
intraocular pressure
terazosin
glaucoma
terazosin hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24201/95A
Other languages
English (en)
Inventor
Takaaki Deguchi
Katsuhiro Inada
Takahiro Ogawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of AU2420195A publication Critical patent/AU2420195A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU24201/95A 1994-05-18 1995-05-15 Pharmaceutical composition for treating glaucoma containing terazosin Abandoned AU2420195A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6-103676 1994-05-18
JP10367694 1994-05-18
PCT/JP1995/000920 WO1995031200A1 (en) 1994-05-18 1995-05-15 Pharmaceutical composition for treating glaucoma containing terazosin

Publications (1)

Publication Number Publication Date
AU2420195A true AU2420195A (en) 1995-12-05

Family

ID=14360400

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24201/95A Abandoned AU2420195A (en) 1994-05-18 1995-05-15 Pharmaceutical composition for treating glaucoma containing terazosin

Country Status (10)

Country Link
EP (1) EP0759756A1 (hu)
JP (1) JPH10500130A (hu)
CN (1) CN1148810A (hu)
AU (1) AU2420195A (hu)
BR (1) BR9507732A (hu)
CA (1) CA2187361A1 (hu)
HU (1) HUT76468A (hu)
PL (1) PL317190A1 (hu)
TW (1) TW304879B (hu)
WO (1) WO1995031200A1 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003004058A1 (en) * 2001-07-02 2003-01-16 Santen Pharmaceutical Co., Ltd. OPTIC NERVE PROTECTING AGENTS CONTAINING α1 RECEPTOR BLOCKER AS THE ACTIVE INGREDIENT
US20040235932A1 (en) * 2001-07-13 2004-11-25 Kenji Yamazaki Ophthalmic pharmaceutical compositions
CN104840436B (zh) * 2015-06-11 2017-12-05 刘磊 药物组合物
JPWO2017002846A1 (ja) * 2015-06-30 2018-05-24 株式会社ニデック 視機能測定装置、および視機能測定プログラム
CN114767688A (zh) * 2019-09-04 2022-07-22 武汉科福新药有限责任公司 透皮促渗组合物及其在噻吗洛尔制剂中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2824863B2 (ja) * 1989-07-12 1998-11-18 エーザイ株式会社 α▲下１▼―ブロッカー点眼剤
ES2038580T3 (es) * 1989-08-03 1994-10-16 Eisai Co Ltd Metodo de fotoestabilizacion de soluciones oftalmicas.
US5256667A (en) * 1991-09-25 1993-10-26 Merck & Co., Inc. Quinazolinones and pyridopyrimidinones

Also Published As

Publication number Publication date
EP0759756A1 (en) 1997-03-05
CA2187361A1 (en) 1995-11-23
CN1148810A (zh) 1997-04-30
TW304879B (hu) 1997-05-11
HU9603158D0 (en) 1997-01-28
JPH10500130A (ja) 1998-01-06
WO1995031200A1 (en) 1995-11-23
HUT76468A (en) 1997-09-29
PL317190A1 (en) 1997-03-17
BR9507732A (pt) 1997-08-19

Similar Documents

Publication Publication Date Title
EP0642789B1 (en) Remedy for glaucoma
EP0093380B1 (en) Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
EP1719774B1 (en) Therapeutic agent for diabetic macular edema
US5837723A (en) Pharmaceutical composition useful for treating ophthalmological diseases
EP0672417A1 (en) Reduction of elevated intraocular pressure
EP1004307B1 (en) Ophthalmic composition
US5527831A (en) Pharmaceutical composition for topical application to the eye for treating increased intraocular pressure
US4565821A (en) Method and ophthalmic composition for treating ocular hypertension and glaucoma with butyrophenones
AU2420195A (en) Pharmaceutical composition for treating glaucoma containing terazosin
US5519030A (en) Method for prophylaxis and treatment of myopia
EP0968716B1 (en) Drugs for ameliorating ocular circulatory disorders
EP1225890B1 (en) Rivastigmine for the treatment of ocular disorders
US5153205A (en) Method to reduce introacular pressure without causing miosis
EP0608604A1 (en) Ajmaline to reduce elevated intraocular pressure
EP0728480A1 (en) Use of ifenprodil for treatment of elevated intraocular pressure
JP2741285B2 (ja) 緑内障治療剤
CN116898800A (zh) 无防腐剂的眼科药物乳剂及其应用
KR20010024889A (ko) 시신경유두 순환 개선제
JPH06211665A (ja) ジラゼプを必須成分とする眼圧降下剤